A study-level meta-analysis of efficacy data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in patients with RAS wild-type metastatic colorectal cancer
暂无分享,去创建一个
J. Douillard | J. Terwey | R. Koukakis | S. Stintzing | Volker Heinemann | Fernando Rivera | Bert H. O’Neil | B. O’neil